Neoantigens Market Analysis: Unveiling Growth Opportunities Amidst Cancer Challenges
The global neoantigens market is on the brink of substantial growth, driven by the escalating prevalence of cancers and other chronic diseases worldwide. Recent data reveals that cancer has overtaken heart disease as the leading cause of death across the globe. According to the World Health Organization (WHO), cancer was the primary cause of death in individuals under 70 years old in 183 countries in 2020, with an alarming 27.5 million new cancer diagnoses expected by 2040, leading to 163 million deaths, as per the International Agency for Research on Cancer (IARC).
The neoantigens market is anticipated to receive a significant boost in the coming years as factors such as lifestyle changes, inadequate physical activity, smoking, and shifting health and climatic conditions contribute to th...